#Abu Dhabi #United Arab Emirates #Financial Growth #PureHealth #Middle East Healthcare

PureHealth's Stellar Financial Performance in Q1 2026

PureHealth Holding PJSC, the leading healthcare group in the Middle East, has announced impressive financial results for the first three months of 2026. As the healthcare landscape continues to evolve, PureHealth has managed to stand out, showcasing resilience and adaptability in its operations.

In Q1 2026, PureHealth reported total revenue of $2.0 billion, marking a 10% increase compared to the same period last year. This growth is largely attributed to the performance of its international healthcare portfolio, as well as its insurance sector known as 'Cover'. The Group's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) also increased, reaching $323 million, which reflects a 5% year-on-year growth.

Net Profit and EBITDA Insights

The net profit for the quarter was $113 million, indicating a robust operational capability despite experiencing limited short-term impacts from ongoing regional challenges. These results underscore PureHealth's commitment to providing quality healthcare services while maintaining financial stability.

H.E. Kamal Al Maazmi, Chairman of PureHealth, expressed that these results signify a strong start to 2026, highlighting the Group's sustainable demand and strategic execution. He emphasized how the integrated Care and Cover model positions PureHealth for stability and long-term growth opportunities, contributing to its substantial progress in both local and international markets.

International Expansion Driving Revenue

A significant component of the revenue growth was attributed to the international care segment, which saw a 60% increase, generating $682 million this quarter. The growth was especially potent due to contributions from the Hellenic Healthcare Group and Circle Health, indicating the Group's expansion strategy is paying dividends. In the United Kingdom, Circle Health reported a 9.5% increase in revenue, primarily driven by growth across inpatient, day-case, and outpatient services.

Conversely, the UAE segment faced a registered 13% decrease in revenue to $745 million, largely due to regulatory shifts resulting from the Unified Purchasing Program introduced in 2025.

Innovations and Strategic Growth

In terms of strategic updates, Circle Health expanded its services, including enhancing hospital capacity and implementing advanced surgical technology, such as the Da Vinci robotic surgical system. The acquisition of Evangelismos Hospital in Cyprus has also been a strategic move to boost PureHealth’s presence in the region.

Technology initiatives have seen PureHealth deploy an AI-powered logistics management solution, marking an essential step toward digitizing operations across the UAE and improving healthcare service delivery.

Positive Outlook for Future Growth

Looking ahead, PureHealth remains optimistic about sustaining growth through the strategic integration of its international portfolio, continuous investments in technology, and expanding its insurance vertical. The focus on enhancing operational efficiency through digital transformation and AI initiatives aims to lead to improved patient experiences and operational performance.

As PureHealth solidifies its position as a prominent international healthcare player, the company is poised to leverage its assets for further growth across diverse healthcare markets. Overall, the financial results portray a trajectory of expansion and strategic versatility, which is essential in today's competitive healthcare environment.

With the backing of a solid balance sheet, bolstered by total assets valued at $15.6 billion, PureHealth's future looks promising in meeting the growing demands of healthcare both regionally and globally.